BIOMERICA INC

BIOMERICA INC is a global biomedical technology company that develops, patents, manufactures, and markets advanced diagnostic and therapeutic products. The company's diagnostic test kits analyze blood, urine, nasal, or fecal material from patients to help diagnose diseases, food intolerances, and other medical conditions. These tests detect and measure specific bacteria, hormones, antibodies, antigens, and other substances in the human body, even at extremely low concentrations. BIOMERICA INC's products aim to improve patient outcomes and well-being while lowering overall healthcare costs. The company sells its diagnostic products worldwide, primarily to clinical laboratories and in point-of-care settings, such as physicians' offices and over-the-counter channels. BIOMERICA INC also offers contract development and manufacturing services to third parties, leveraging the technology behind its products. Additionally, the company is commercializing its inFoods® IBS product through physician-directed and laboratory-based channels, including third-party reimbursement pathways. Most of BIOMERICA INC's products have Conformité Européenne ("CE") marking and/or are registered with regulatory agencies in various countries for diagnostic use, with several also cleared by the United States Food and Drug Administration ("FDA") for sale in the United States. The company focuses on developing and marketing accurate diagnostic products that use easily obtained patient specimens and, when appropriate, can be performed without complex instrumentation. BIOMERICA INC invests in research and development for new diagnostic products and technologies to address various medical conditions and unmet clinical needs.